• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对新墨西哥州人群中SARS-CoV-2感染抗体反应的纵向评估。

A longitudinal assessment of the antibody response to SARS-CoV-2 infection in the New Mexican population.

作者信息

Twohig Frances M, Baranowski Tonilynn M, Ye Chunyan, Harkins Michelle, Bradfute Steven B

机构信息

Department of Internal Medicine, Center for Global Health, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.

Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.

出版信息

PLoS One. 2025 Jul 8;20(7):e0327698. doi: 10.1371/journal.pone.0327698. eCollection 2025.

DOI:10.1371/journal.pone.0327698
PMID:40627802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12237266/
Abstract

While many studies have assessed immune responses to SARS-CoV-2 infection, none have studied functional antibody responses before and after vaccination of exposed patients in New Mexico in the United States. Here, we evaluate antibody binding, antibody neutralization, and antibody dependent cell-mediated cytotoxicity (ADCC) responses from convalescent patients between September 2020 and April 2021. Our results indicate that binding, neutralizing, and ADCC titers remained durable over an estimated 4-month period or were boosted by vaccination. Antibody binding titer stability was comparable to that of antibodies against four common viruses. Hispanic and Latino responses were similar to non-Hispanic/Latino responses in this cohort. Overall, these data shed light on functional antibody responses to SARS-CoV-2 in pre-alpha variant waves in New Mexico.

摘要

虽然许多研究评估了对SARS-CoV-2感染的免疫反应,但在美国新墨西哥州,尚无研究对暴露患者接种疫苗前后的功能性抗体反应进行研究。在此,我们评估了2020年9月至2021年4月期间康复患者的抗体结合、抗体中和及抗体依赖性细胞介导的细胞毒性(ADCC)反应。我们的结果表明,结合、中和及ADCC滴度在大约4个月的时间内保持持久,或通过接种疫苗得到增强。抗体结合滴度稳定性与针对四种常见病毒的抗体相当。在该队列中,西班牙裔和拉丁裔的反应与非西班牙裔/拉丁裔的反应相似。总体而言,这些数据揭示了新墨西哥州在阿尔法变体出现之前的浪潮中对SARS-CoV-2的功能性抗体反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a3/12237266/fd232b346fea/pone.0327698.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a3/12237266/9bd81f2605f0/pone.0327698.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a3/12237266/8dbbb7483011/pone.0327698.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a3/12237266/0ac7e61c547b/pone.0327698.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a3/12237266/fd232b346fea/pone.0327698.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a3/12237266/9bd81f2605f0/pone.0327698.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a3/12237266/8dbbb7483011/pone.0327698.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a3/12237266/0ac7e61c547b/pone.0327698.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1a3/12237266/fd232b346fea/pone.0327698.g004.jpg

相似文献

1
A longitudinal assessment of the antibody response to SARS-CoV-2 infection in the New Mexican population.对新墨西哥州人群中SARS-CoV-2感染抗体反应的纵向评估。
PLoS One. 2025 Jul 8;20(7):e0327698. doi: 10.1371/journal.pone.0327698. eCollection 2025.
2
Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.在整个 COVID-19 大流行期间健康献血者的抗 SARS-CoV-2 总免疫球蛋白和中和抗体反应:一项纵向观察研究。
Swiss Med Wkly. 2024 Jul 1;154:3408. doi: 10.57187/s.3408.
3
The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2.早期使用康复期血浆治疗新冠病毒病对严重急性呼吸综合征冠状病毒2抗体反应的影响。
Microbiol Spectr. 2025 Jul;13(7):e0300624. doi: 10.1128/spectrum.03006-24. Epub 2025 Jun 9.
4
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
5
Establishment of human post-vaccination SARS-CoV-2 standard reference sera.建立人接种 SARS-CoV-2 疫苗后标准参考血清。
J Immunol Methods. 2024 Jul;530:113698. doi: 10.1016/j.jim.2024.113698. Epub 2024 May 31.
6
Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia.哥伦比亚对新冠病毒疫苗接种特异性抗体反应的纵向随访
J Med Virol. 2025 Jan;97(1):e70133. doi: 10.1002/jmv.70133.
7
Immunogenicity and safety of CoronaVac vaccine in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.科兴新冠疫苗在儿童和青少年中的免疫原性及安全性(巴西Immunita-002研究):IV期六个月随访
Sci Rep. 2025 Jul 2;15(1):23040. doi: 10.1038/s41598-025-94596-9.
8
Antibody Levels From High-Throughput Variant-Specific SARS-CoV-2 Anti-Spike Immunoglobulin G and Angiotensin-Converting Enzyme 2 Neutralization Assays Correlate With COVID-19 Infection Risk in a Large Population.高通量变异株特异性SARS-CoV-2抗刺突免疫球蛋白G和血管紧张素转换酶2中和试验检测的抗体水平与大量人群的COVID-19感染风险相关。
J Infect Dis. 2025 Apr 15;231(4):921-930. doi: 10.1093/infdis/jiae622.
9
Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis.慢性淋巴细胞白血病患者中SARS-CoV-2疫苗接种的免疫反应动力学:一项描述性分析
Front Immunol. 2025 Jun 6;16:1571680. doi: 10.3389/fimmu.2025.1571680. eCollection 2025.
10
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.针对刺突蛋白的单克隆抗体改变了对 SARS-CoV-2 疫苗接种和感染的内源性体液免疫反应。
Sci Transl Med. 2024 Nov 6;16(772):eadn0396. doi: 10.1126/scitranslmed.adn0396.

本文引用的文献

1
SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.SARS-CoV-2 感染引发的抗体依赖细胞介导的细胞毒性(ADCC)反应强于基于 mRNA、载体和灭活病毒的 COVID-19 疫苗。
J Med Virol. 2024 Mar;96(3):e29527. doi: 10.1002/jmv.29527.
2
The humoral response and antibodies against SARS-CoV-2 infection.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的体液免疫反应及抗体
Nat Immunol. 2022 Jul;23(7):1008-1020. doi: 10.1038/s41590-022-01248-5. Epub 2022 Jun 27.
3
Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients.
自然杀伤细胞介导的 ADCC 在 SARS-CoV-2 感染个体和疫苗接种者中的作用。
Eur J Immunol. 2022 Aug;52(8):1297-1307. doi: 10.1002/eji.202149470. Epub 2022 Apr 22.
4
Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination.自然杀伤细胞介导的针对 SARS-CoV-2 的抗体依赖的细胞细胞毒性在自然感染后比在接种疫苗后更强。
J Infect Dis. 2022 May 16;225(10):1688-1693. doi: 10.1093/infdis/jiac060.
5
Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies.抗 SARS-CoV-2 IgG 抗体的长期持久性。
Curr Microbiol. 2022 Feb 12;79(4):96. doi: 10.1007/s00284-022-02800-0.
6
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants.接种疫苗无论是在感染 SARS-CoV-2 之前还是之后,都会引发强烈的体液免疫反应和能够有效中和变异株的抗体。
Sci Immunol. 2022 Feb 18;7(68):eabn8014. doi: 10.1126/sciimmunol.abn8014.
7
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients.COVID-19 患者对 SARS-CoV-2 的抗体依赖细胞细胞毒性反应。
Signal Transduct Target Ther. 2021 Sep 24;6(1):346. doi: 10.1038/s41392-021-00759-1.
8
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses.单剂量的新冠病毒疫苗BNT162b2可引发Fc介导的抗体效应功能和T细胞反应。
Cell Host Microbe. 2021 Jul 14;29(7):1137-1150.e6. doi: 10.1016/j.chom.2021.06.001. Epub 2021 Jun 4.
9
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
10
Decay of Fc-dependent antibody functions after mild to moderate COVID-19.轻度至中度 COVID-19 后 Fc 依赖性抗体功能的衰减。
Cell Rep Med. 2021 Jun 15;2(6):100296. doi: 10.1016/j.xcrm.2021.100296. Epub 2021 May 9.